Cumulative exposure to ionising radiation in adults with interstitial lung disease (ILD)

L. Taha, D. Nazareth, S. Kazmi, M. Walshaw (Liverpool, United Kingdom)

Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Taha, D. Nazareth, S. Kazmi, M. Walshaw (Liverpool, United Kingdom). Cumulative exposure to ionising radiation in adults with interstitial lung disease (ILD). Eur Respir J 2012; 40: Suppl. 56, 277

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cumulative exposure to ionising radiation in adults with non-CF bronchiectasis
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012

Idiopathic pulmonary fibrosis: asbestos exposure, smoking and lung cancer risk
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) and smoking cessation in exposed to low-dose radiation
Source: Annual Congress 2008 - Lung function in respiratory disease
Year: 2008

Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) at the remote period after radiation exposure
Source: Eur Respir J 2007; 30: Suppl. 51, 338s
Year: 2007

Is ionizing radiation the risk factor for chronic obstructive pulmonary disease?
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Cellular biomarkers in chronic obstructive pulmonary disease in radiation exposed
Source: Annual Congress 2007 - Biomarkers in inflammatory lung disease
Year: 2007


Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009


Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Non-asbestos related respiratory disease and lung function in an asbestos exposed cohort
Source: Annual Congress 2010 - Mineral dusts and respiratory disease
Year: 2010


Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Markers of injury and fibrosis in occupational interstitial lung diseases (OILD)
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Does asbestos exposure cause chronic obstructive lung disease?
Source: Eur Respir J 2007; 30: Suppl. 51, 159s
Year: 2007

Occupational interstitial lung disease
Source: Eur Respir Mon; 2009: 46: 265–286
Year: 2009

Safety of sputum induction (SI) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Changes in occupational exposure as a risk factor for obstructive lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 322s
Year: 2002

Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016


Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD)
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017